39
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Expression and cDNA Sequence of Matrix Metalloproteinase-2 (MMP-2) in a Mammalian Model of Human Disease Processes: Tupaia belangeri

, &
Pages 332-337 | Published online: 11 Jul 2009

References

  • Araya J., Maruyama M., Sassa K., Fujita T., Hayashi R., Matsui S., Kashii T., Yamashita N., Sugiyama E. and Kobayashi M. (2001) “Ionizing radiation enhances matrix metalloproteinase-2 production in human lung epithelial cells”, American Journal of Physiology. Lung Cellular and Molecular Physiology 280, L30-L38.
  • Cao J., Yang, E.B., Su, J.J., Li Y. and Chow P. (2003) “The tree shrews: adjuncts and alternatives to primates as models for biomedical research”, Journal of Medical Primatology 32, 123-130.
  • Chomczynski P. and Sacchi N. (1987) “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction”, Analytical Biochemistry 162, 156-159.
  • Czeh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A. and Fuchs E. (2001) “Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepress-ant treatment with tianeptine”, Proceedings of the National Academy of Sciences of the United States of America 98, 12796-12801.
  • Galardy, R.E., Cassabonne, M.E., Giese C., Gilbert, J.H., Lapierre F., Lopez H., Schaefer, M.E., Stack R., Sullivan M., Summers B., et al. (1994) “Low molecular weight inhibitors in corneal ulcera-tion”, Annals of the New York Academy of Sciences 732, 315-323.
  • Gentle A., Anastasopoulos F. and McBrien, N.A. (2001) “High-resolution semiquantitative real-time PCR without the use of a standard curve”, Biotechniques 31, 502, 504-6, 508.
  • Guggenheim, J.A. and McBrien, N.A. (1996) “Form-deprivation myopia induces activation of scleral matrix metalloprotei-nase-2 in tree shrew”, Investigative Ophthalmology and Visual Science 37, 1380-1395.
  • Huhtala P., Chow, L.T. and Tryggvason K. (1990) “Structure of the human type IV collagenase gene”, Journal of Biological Chemistry 265, 11077-11082.
  • Kock J., Nassal M., MacNelly S., Baumert, T.F., Blum, H.E. and von Weizsacker F. (2001) “Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus”, Journal of Virology 75, 5084-5089.
  • Luckett, W.P. (1980) Comparative Biology and Evolutionary Relation-ships of Tree Shrews (Plenum Press, New York).
  • Martignetti, J.A., Aqeel, A.A., Sewairi, W.A., Boumah, C.E., Kambouris M., Mayouf, S.A., Sheth, K.V., Eid, W.A., Dowling O., Harris J., Glucksman, M.J., Bahabri S., Meyer, B.F. and Desnick, R.J. (2001) “Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome”, Nature Genetics 28, 261-265.
  • Massova I., Kotra, L.P., Fridman R. and Mobashery S. (1998) “Matrix metalloproteinases: structures, evolution, and diver-sification”, The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 12, 1075-1095.
  • Matsumoto S., Katoh M., Watanabe T. and Masuho Y. (1996) “Molecular cloning of rabbit matrix metalloproteinase-2 and its broad expression at several tissues”, Biochimica et Biophysica Acta 1307, 137-139.
  • McBrien, N.A. and Gentle A. (2003) “Role of the sclera in the development and pathological complications of myopia”, Progress in Retinal and Eye Research 22, 307-338.
  • McBrien, N.A. and Norton, T.T. (1992) “The development of experimental myopia and ocular component dimensions in monocularly lid-sutured tree shrews (Tupaia belangeri)”, Vision Research 32, 843-852.
  • Murawaki Y., Yamada S., Ikuta Y. and Kawasaki H. (1999) “Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease”, Journal of Hepatology 30, 1090-1098.
  • Nagase H. and Woessner, J.F., Jr. (1999) “Matrix metalloprotei-nases”, The Journal of Biological Chemistry 274, 21491-21494.
  • NHMRC (1997) Australian Code of Practice for the Care and Use of Animals for Scientific Purposes (Australian Government Publishing Service).
  • Park, U.S., Su, J.J., Ban, K.C., Qin L., Lee, E.H. and Lee, Y.I. (2000) “Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1”, Gene 251, 73-80.
  • Reponen P., Sahlberg C., Huhtala P., Hurskainen T., Thesleff I. and Tryggvason K. (1992) “Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development”, The Journal of Biological Chemistry 267, 7856-7862.
  • Salzmann J., Limb, G.A., Khaw, P.T., Gregor, Z.J., Webster L., Chignell, A.H. and Charteris, D.G. (2000) “Matrix metallo-proteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy”, The British Journal of Ophthalmology 84, 1091-1096.
  • Sato H., Takino T., Okada Y., Cao J., Shinagawa A., Yamamoto, E. and Seiki M. (1994) “A matrix metalloproteinase expressed on the surface of invasive tumour cells”, Nature 370, 61-65.
  • Siegwart, J.T., Jr. and Norton, T.T. (2001) “Steady state mRNA levels in tree shrew sclera with form-deprivation myopia and during recovery”, Investigative Ophthalmology & Visual Science 42, 1153-1159.
  • Tattersall I. (1984) “The tree-shrew, Tupaia: a “living model” of the ancestral primate?”, In: Etdredge N. and Stanley, S.M., eds, Living Fossils (Springer-Verlag, New York).
  • Wielockx B., Lannoy K., Shapiro, S.D., Itoh T., Itohara S., Vandekerckhove J. and Libert C. (2001) “Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy”, Nature medicine 7, 1202-1208.
  • Woessner, J.F. (1991) “Matrix metalloproteinases and their inhibitors in connective tissue remodeling”, The FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 5, 2145-2154.
  • Woessner, J.F. and Nagase H. (2000) Matrix Metalloproteinases and TIMPs (Oxford University Press, Oxford).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.